BCL2L1 and breast carcinoma: The five antiapoptotic genes (BCL2, BCL2A1, BCL2L1, BCL2L2, and MCL1) are frequently overexpressed in ER-positive breast cancer cells, and these genes have been used as clinical biomarkers in the diagnosis of breast cancer [9–12].